Evercore ISI Group Maintains In-Line on Edwards Lifesciences, Raises Price Target to $91
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $89 to $91.
July 02, 2024 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group has maintained an In-Line rating on Edwards Lifesciences and raised the price target from $89 to $91.
The raised price target from $89 to $91 by Evercore ISI Group suggests a positive outlook for Edwards Lifesciences, which could lead to a short-term increase in stock price. However, the In-Line rating indicates a neutral stance, balancing the impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100